Menu

All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and latest CE information More Information

Featured Activity

This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

SHOW SEARCH

From the Front Line: Improving Sterile Compounding Safety

Activity Downloads

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.

NOTE: If you attended the live CE activity titled "From the Front Line: Improving Sterile Compounding Safety" that was held on December 5, 2016 during the 51st ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada AND received CE credit (i.e. a pharmacist or pharmacy technician CE statement with ACPE Universal Activity Number 0221-9999-16-319-L05-P/T), you are ineligible to also receive CE credit for this home-study activity.

Activity Description

Sterile product compounding is associated with more risk factors than many other areas of medication use; this activity will highlight the experience of one pharmacy director who was challenged to respond to a fatal compounding error and led his team through a time of uncertainty and transformational change. Other expert speakers will address risk points and risk reduction strategies, explore the use of technology to augment manual processes for preparation and verification of sterile products, and highlight changes made in the recently updated ISMP guidelines for sterile compounding.

Learning Objectives

The target audience for this activity includes pharmacists and pharmacy technicians. Upon completion of this activity, participants will be able to:

  • Identify key components of a pharmacy department's response to a fatal error and how to lead through transformational change
  • List the benefits of introducing technology into the sterile compounding process
  • Describe the pharmacist and pharmacy technician process steps when using IV workflow software
  • Discuss the changes presented in the recently updated ISMP Guidelines for Safe Preparation of Compounded Sterile Preparations

Faculty

Moderator: Michael R. Cohen, RPh, MS, ScD (hon.), DPS (hon.), FASHP
President
Institute for Safe Medication Practices
Horsham, Pennsylvania

Derek Gillespie, RPh
Pharmacy Operations Manager
Renown Regional Medical Center
Reno, Nevada

Christina Michalek, BS, FASHP
Medication Safety Specialist
Institute for Safe Medication Practices
Horsham, Pennsylvania

Kelley M. Reece, PharmD
Assistant Pharmacy Manager-Ambulatory Treatment Center
MD Anderson Cancer Center
Houston, Texas

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. All of the faculty speakers have no relevant commercial or financial relationships to disclose.

Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

CE Accreditation

Release Date: 02-28-2017
Expiration Date: 02-28-2019

Pharmacists and Pharmacy Technicians

This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-17-087-H05-P/T has been assigned to this knowledge-based home-study CE activity (initial release date 2-28-17). This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Funding

This CE activity is supported by an educational grant from BD.

 

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.